AstraZeneca

• J&J’s COVID-19 vaccine restricted by FDA due to rare but serious blood clot risk

  U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.

  Health

  May 5
  
• COVID-19: Booster shot uptake rises in Sask. as province adds 829 new cases, 14 deaths

  There were 829 new COVID-19 cases confirmed last week in Saskatchewan with 231 cases found in the Saskatoon zone and 141 in the Regina zone.

  Health

  Apr 28
  
• Advertisement
• Health Canada OKs AstraZeneca’s Evusheld drug for COVID-19 prevention

  AstraZeneca's Evusheld contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.

  Canada

  Apr 14
• Advertisement
• AstraZeneca forecasts 2022 growth even as COVID revenue wanes

  While sales of COVID-19 products are expected to decline by a low-to-mid 20s percentage this year, Astrazeneca forecast overall revenues to rise by a high teens percentage.

  Consumer

  Feb 10
• AstraZeneca says it is working on an Omicron vaccine with Oxford

  "Together with Oxford University, we have taken preliminary steps in producing an Omicron variant vaccine, in case it is needed," a spokesperson for the company said.

  World

  Dec 21, 2021
• FDA approves 1st COVID-19 antibody drug intended for long-term prevention

  People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs.

  World

  Dec 8, 2021
• Omicron variant: AstraZeneca exploring impact on vaccine, antibody cocktail

  AstraZeneca said that it had developed a vaccine platform to respond quickly to new variants with Oxford University, where its vaccine was created.

  World

  Nov 26, 2021
• AstraZeneca says COVID-19 antibody drug 83% effective over six months

  AstraZeneca's treatment is given in one go, as two sequential shots in the arm.

  Health

  Nov 18, 2021
• Advertisement
• Federal funding to aid expansion of Hamilton-based lab studying vaccine-related blood clots

  During the pandemic, the McMaster Platelet Immunology Laboratory (MPIL) has been studying VITT – an affliction identified in some COVID-19 vaccine recipients.

  Health

  Nov 10, 2021
• Advertisement
• COVID-19: Booster shot eligibility opens for some Ontario at risk groups today

  Starting today, those who are aged 70 and older, health-care workers, essential caregivers in congregate settings, and adults in Indigenous communities can book an appointment.

  Health

  Nov 6, 2021